Cardiovascular morbidity and mortality after kidney transplantation

Area of Science:

• Nephrology
• Cardiology
• Transplantation Medicine

Background:

• Patients with end-stage renal disease (ESRD) have significantly higher cardiovascular (CV) risk than the general population.
• Cardiovascular disease is the primary cause of mortality and graft failure in kidney transplant recipients.
• Kidney transplant recipients present with prevalent traditional CV risk factors and unique transplant-related risks.

Purpose of the Study:

• To review the mechanisms of excess CV morbidity and mortality in kidney transplant recipients.
• To examine current evidence and strategies for mitigating CV risk in this patient group.

Main Methods:

• Literature review focusing on cardiovascular risk factors in kidney transplant recipients.
• Analysis of conventional risk factors (hypertension, diabetes, dyslipidemia, ischemic heart disease).
• Evaluation of transplant-specific risks (immunosuppression side effects, graft dysfunction, post-transplantation diabetes).

Main Results:

• Kidney transplant recipients exhibit a high prevalence of traditional cardiovascular risk factors.
• Transplantation introduces specific risks including immunosuppression complications and impaired graft function.
• Cardiovascular disease remains a leading cause of death and graft loss post-transplantation.

Conclusions:

• Optimizing cardiovascular health is essential for kidney transplant recipients.
• Strategies include pharmacological interventions, optimizing graft function, lifestyle changes, and personalized immunosuppression.
• Addressing both traditional and transplant-specific risk factors can improve CV outcomes and graft survival.